JP2022538301A5 - - Google Patents

Info

Publication number
JP2022538301A5
JP2022538301A5 JP2021577427A JP2021577427A JP2022538301A5 JP 2022538301 A5 JP2022538301 A5 JP 2022538301A5 JP 2021577427 A JP2021577427 A JP 2021577427A JP 2021577427 A JP2021577427 A JP 2021577427A JP 2022538301 A5 JP2022538301 A5 JP 2022538301A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
compound
hydrogen
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021577427A
Other languages
English (en)
Japanese (ja)
Other versions
JP7670632B2 (ja
JP2022538301A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/040164 external-priority patent/WO2020264512A1/en
Publication of JP2022538301A publication Critical patent/JP2022538301A/ja
Publication of JP2022538301A5 publication Critical patent/JP2022538301A5/ja
Priority to JP2025017657A priority Critical patent/JP2025065311A/ja
Application granted granted Critical
Publication of JP7670632B2 publication Critical patent/JP7670632B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021577427A 2019-06-27 2020-06-29 Cns障害を治療するための組成物及び方法 Active JP7670632B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025017657A JP2025065311A (ja) 2019-06-27 2025-02-05 Cns障害を治療するための組成物及び方法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962867695P 2019-06-27 2019-06-27
US201962867734P 2019-06-27 2019-06-27
US201962867736P 2019-06-27 2019-06-27
US62/867,736 2019-06-27
US62/867,695 2019-06-27
US62/867,734 2019-06-27
PCT/US2020/040164 WO2020264512A1 (en) 2019-06-27 2020-06-29 Compounds for treating cns disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025017657A Division JP2025065311A (ja) 2019-06-27 2025-02-05 Cns障害を治療するための組成物及び方法

Publications (3)

Publication Number Publication Date
JP2022538301A JP2022538301A (ja) 2022-09-01
JP2022538301A5 true JP2022538301A5 (cg-RX-API-DMAC7.html) 2023-07-11
JP7670632B2 JP7670632B2 (ja) 2025-04-30

Family

ID=71728948

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021577427A Active JP7670632B2 (ja) 2019-06-27 2020-06-29 Cns障害を治療するための組成物及び方法
JP2025017657A Pending JP2025065311A (ja) 2019-06-27 2025-02-05 Cns障害を治療するための組成物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025017657A Pending JP2025065311A (ja) 2019-06-27 2025-02-05 Cns障害を治療するための組成物及び方法

Country Status (10)

Country Link
US (2) US20230257415A1 (cg-RX-API-DMAC7.html)
EP (1) EP3990468A1 (cg-RX-API-DMAC7.html)
JP (2) JP7670632B2 (cg-RX-API-DMAC7.html)
CN (1) CN114729000A (cg-RX-API-DMAC7.html)
AU (1) AU2020304679A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021026445A2 (cg-RX-API-DMAC7.html)
CA (1) CA3143545A1 (cg-RX-API-DMAC7.html)
MX (1) MX428310B (cg-RX-API-DMAC7.html)
TW (1) TWI896548B (cg-RX-API-DMAC7.html)
WO (1) WO2020264512A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS62761B1 (sr) 2012-08-21 2022-01-31 Sage Therapeutics Inc Alopregnanolon za lečenje refraktornog epileptičkog statusa
SMT202100509T1 (it) 2013-04-17 2021-11-12 Sage Therapeutics Inc Steroide di c21-n-pirazolile 19-nor c3,3-disostituito per l'uso in terapia
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
JOP20200195A1 (ar) 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
WO2016082789A1 (en) 2014-11-27 2016-06-02 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
WO2018013613A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C17, c20, and c21 substituted neuroactive steroids and their methods of use
TW202604538A (zh) 2016-08-23 2026-02-01 美商賽吉醫療公司 結晶19-去甲c3,3-二取代之c21-n-吡唑類固醇
US20200291059A1 (en) 2017-12-08 2020-09-17 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
AU2019357040B2 (en) 2018-10-12 2025-03-27 Sage Therapeutics, Inc. Neuroactive steroids substituted in position 10 with a cyclic group for use in the treatment of CNS disorders
IL312610B2 (en) 2018-12-05 2026-05-01 Sage Therapeutics Llc Neuroactive steroids and methods of using them
CN111410678B (zh) 2019-01-08 2023-02-28 成都康弘药业集团股份有限公司 甾体类化合物、用途及其制备方法
JP7670626B2 (ja) 2019-05-31 2025-04-30 セージ セラピューティクス, インコーポレイテッド 神経刺激性ステロイド及びその組成物
JP7787635B2 (ja) 2019-06-27 2025-12-17 セージ セラピューティクス, エルエルシー Cns障害を治療するための組成物及び方法
AU2021238346A1 (en) 2020-03-18 2022-09-29 Sage Therapeutics, Inc. Neuroactive steroids and their methods of use

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2969M (fr) * 1963-05-22 1964-11-30 Roussel Uclaf Nouveau médicament notamment pour le traitement des spasmes d'origine coronarienne on viscérale.
ES432106A1 (es) * 1973-11-30 1976-11-01 Schering Ag Procedimiento para la preparacion de d-homo-20-cetopregna- nos.
IL48628A0 (en) * 1974-12-23 1976-02-29 Schering Ag D-homo-20-keto-pregnanes and process for their manufactur
GB1570394A (en) * 1976-01-06 1980-07-02 Glaxo Lab Ltd 11-acyloxy-3-hydroxy steroids
GB1581234A (en) * 1976-04-05 1980-12-10 Glaxo Operations Ltd 11a - amino - 3a - hydroxysteroids
GB1581235A (en) * 1977-04-04 1980-12-10 Glaxo Operations Ltd 11a-amino-3a-hydroxy-steroids
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
BR9509764A (pt) * 1994-11-23 1998-07-07 Cocensys Inc Série androstano e pregnano para modulação alostérica de receptor de gaba
AU3967297A (en) * 1996-08-01 1998-02-25 Cocensys, Inc. Use of gaba and nmda receptor ligands for the treatment of migraine headache
SMT202100509T1 (it) 2013-04-17 2021-11-12 Sage Therapeutics Inc Steroide di c21-n-pirazolile 19-nor c3,3-disostituito per l'uso in terapia
DK3258939T3 (da) 2015-02-20 2022-12-12 Sage Therapeutics Inc Neuroaktive steroider, sammensætninger og anvendelser heraf
WO2018013613A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C17, c20, and c21 substituted neuroactive steroids and their methods of use
EP3728285B1 (en) 2017-12-22 2026-04-08 Sage Therapeutics, LLC Compositions and methods for treating cns disorders
MX2020008182A (es) * 2018-02-11 2020-09-22 Jiangsu Hansoh Pharmaceutical Group Co Ltd Reguladores de derivados esteroides, metodo para prepararlos y usos de los mismos.
US12139508B2 (en) * 2018-02-11 2024-11-12 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Steroid derivative regulators, method for preparing the same, and uses thereof
IL312610B2 (en) 2018-12-05 2026-05-01 Sage Therapeutics Llc Neuroactive steroids and methods of using them

Similar Documents

Publication Publication Date Title
JP2022538299A5 (cg-RX-API-DMAC7.html)
JP2022510683A5 (cg-RX-API-DMAC7.html)
JP4344235B2 (ja) タキソール増強剤化合物
US7402605B2 (en) 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
TWI354666B (en) Heterocyclic aspartyl protease inhibitors
JP2023518411A5 (cg-RX-API-DMAC7.html)
JP2022538300A5 (cg-RX-API-DMAC7.html)
JP2022544714A5 (cg-RX-API-DMAC7.html)
JP2018502891A5 (cg-RX-API-DMAC7.html)
JP2021523221A5 (cg-RX-API-DMAC7.html)
JP2022516469A5 (cg-RX-API-DMAC7.html)
JP2006515858A5 (cg-RX-API-DMAC7.html)
JP2021534124A5 (cg-RX-API-DMAC7.html)
RU2020123151A (ru) Антагонисты tlr7/8 и их применение
JP2023515617A5 (cg-RX-API-DMAC7.html)
JP2021510695A5 (cg-RX-API-DMAC7.html)
JP2022514385A5 (cg-RX-API-DMAC7.html)
JP2022525069A5 (cg-RX-API-DMAC7.html)
JP2020535165A5 (cg-RX-API-DMAC7.html)
RU2017145650A (ru) Ингибиторы тирозинкиназы брутона
JP2022504607A5 (cg-RX-API-DMAC7.html)
JP2009537546A5 (cg-RX-API-DMAC7.html)
JP2022548250A5 (cg-RX-API-DMAC7.html)
JP2023553428A5 (cg-RX-API-DMAC7.html)
JP2023504542A5 (cg-RX-API-DMAC7.html)